Menu Menu

SCNI    Scinai Immunotherapeutics Ltd    1611747    
Income Statement
Revenue 284,000
Net Income -4,481,000
Profit Margin -1577.82%

Balance Sheet
Current Assets 3,657,000
Assets 14,851,000
Current Liabilities 1,672,000
Liabilities 22,135,000
Equity -7,284,000
Shares Out 3,354,314,000

Cash Flow Statement
Operating Cash Flow -3,221,000
Investing Cash Flow -8,000

Market Analysis
Market Cap 2,793,443
Price 3.51
BVPS 7.47
PB 0.47
EPS -9.04
PS 9.84
FCF -3,229,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Find a discrepancy? The most accurate way to find company fundamental data is to view SCNI documents filed with the SEC.


SCNI Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: